Bupa has revealed critical illness non-disclosure resulted in only 2% of payout refusals between January and September 2009.
Figures for the first three-quarters of 2009 show that a total of 11% of its critical illness claims were rejected. The 2% figure is significantly down on 8.6% for the same period in 2008, while 9% were turned down because they did not meet the policy definition, compared to 10.6% in the same period the previous year. Steve Casey, head of product development at Bupa Individual Protection, noted that 4% of all claims were for children, the majority of which were for leukemia, and that the largest claim paid was for £1m. Casey put the provider's marked improvement down to the product...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes